Christophe Douat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Medincell to Present at the 2024 Jefferies Global Healthcare Conference, June 4 to 6, 2024, New York

Regulatory News: Medincell (Paris:MEDCL): Christophe Douat, CEO, and Richard Malamut, CMO, will present Medincell's portfolio and R&D pipeline at the Jefferies Global Healthcare Conference on

United statesNew yorkLouis victor delouvrier alban dufumierDavid heuzArthur rouillRichard malamutChristophe douatGlobal healthMarriott marquis hotelFinancial communicationsTeva pharmaceuticalsRegulatory newsJefferies global healthcare conferenceGrace kimMedincell headDes march

Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV- 749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia

Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV- 749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United statesChristophe douatMedincell euronextChristoph correllEric hughesTeva pharmaceuticalsTeva pharmaceutical industries ltdZucker school of medicineMedincell announce positive phaseOnce monthly subcutaneous long acting injectableNegative syndrome scaleTeva pharmaceutical industriesRelease injection studyClinical global impressionsSocial performance scaleExecutive vice president

Phase 3 SOLARIS Trial Demonstrates Potential of TEV- 749 in Schizophrenia

Phase 3 SOLARIS Trial Demonstrates Potential of TEV- 749 in Schizophrenia
psychiatrictimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from psychiatrictimes.com Daily Mail and Mail on Sunday newspapers.

Christophe douatChristoph correllEric hughesZucker school of medicineDrug administrationTeva pharmaceuticalsNegative syndrome scaleClinical global impressionsSocial performance scaleZucker school

Unitaid Awards Medincell up to $6 million Extension Grant to Fight Malaria

MONTPELLIER, France, April 08, 2024 Regulatory News: Global health agency Unitaid has awarded Medincell (Paris:MEDCL) an extension grant of up to US$ 6 million over three years to fund the clinical phase 1 activities of long-acting injectable mdc-STM. If proven safe, effective, and acceptable, mdc-STM could have a significant impact on transmission of malaria among vulnerable populations in high-transmission areas.

United statesChristophe douatDavid heuzTeva pharmaceuticalsFinancial communicationsHead of global health development at medincellRegulatory newsGlobal health developmentMalaria reportGlobal technical strategyMedicines patent poolDes marchGlobal healthMalaria transmissionSubcutaneous injectionInjectable formulation

MedinCell to Present at the 23rd Annual Needham Virtual Healthcare Conference

MedinCell to Present at the 23rd Annual Needham Virtual Healthcare Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDavid heuzRichard malamutLouis victor delouvrier alban dufumierChristophe douatFinancial communicationsArthritis innovation corporationTeva pharmaceuticalsAnnual needham virtual healthcare conferenceDes march